|
|
Article: American Home Products Announces Effexor(R) XR Receives FDA Approval for the Treatment of Generalized Anxiety Disorder.
- Article from:
- PR Newswire
- Article date:
- March 11, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- First and only product indicated for both depression and GAD -
MADISON, N.J., March 11 /PRNewswire/ -- American Home Products Corporation (NYSE: AHP) and its Wyeth-Ayerst Laboratories division today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Effexor(R) XR (venlafaxine HCl) Extended-Release Capsules, already indicated for depression, for the treatment of Generalized Anxiety Disorder (GAD). Effexor XR is the first and only antidepressant proven effective in relieving GAD. Generalized Anxiety Disorder is one of the most prevalent anxiety disorders, estimated to affect approximately five percent of people; nearly ...